Sign in
4

Changes in Ownership

Definium Therapeutics, Inc. Filed Acc 0000950170-24-036578

Chief Financial Officer gave up 5,560 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Greenway Schond L. Chief Financial Officer 2024-03-25 Shares withheld for taxes −5,560 $9.78 $54,377 211,057 D
Loading xslF345X05/ownership.xml…